EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hospitalist Care for Unplanned Oncology Admissions: A Mixed‐Method Analysis of Oncology and General Hospitalist Outcomes and Processes

Megan A Mullins iD, Sanah Ladhani iD, Abril Carrillo, Emily C Repasky iD, Michael Wu, Bella Etingen, Emre Tarhan, Navid Sadeghi iD, Jason B Fleming, Suzanne D Conzen, Arthur S Hong

Cancer Medicine · 2026-03 · 15 (3)

DOI: 10.1002/cam4.71679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 24.02.2026. Verfasst von Megan A Mullins und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Economics, Systems, and Policy, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Da…. Hauptthemen laut MEDLINE: Hospitalists, Neoplasms, Medical Oncology. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Texas Health Resources Clinical Scholar Award, National Center for Advancing Translational Sciences of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To compare patient outcomes across oncology hospitalist (OH) and general hospitalist (GH) teams and understand related team practices.

Methods

Using an explanatory sequential mixed‐methods design, we compared unplanned inpatient admissions to the GH or OH teams at our academic medical center between 2018 and 2022 using propensity‐score matching to balance characteristics across teams. Primary outcomes included outpatient oncology follow‐up, 30‐day readmission, and discharge to hospice. Outcomes were modeled with multivariable logistic regression, adjusted for age, race, and comorbidity. We conducted semi‐structured interviews with OH ( n = 6), GH ( n = 7), and oncology consult team ( n = 4) clinicians. Themes were identified through rapid qualitative analysis and consensus discussions between two qualitative researchers.

Results

The matched sample included 1082 GH and 361 OH team admissions. Median length of stay was 5 days (IQR 3,8) for GH and 6 days for OH (IQR 4, 10) ( p < 0.01). The OH team had higher adjusted odds of discharge to hospice (aOR: 1.9, 95% CI: 1.1–3.5), outpatient oncology follow‐up within 30 days (aOR: 4.2, 95% CI: 3.1–5.6), but also 30‐day readmissions (aOR: 1.8, 95% CI: 1.3–2.5) compared to the GH team. The OH team communicated directly with outpatient oncology throughout hospitalizations and sent discharge summaries with follow‐up recommendations. In contrast, the GH team relied on the consulting oncology team to communicate with outpatient oncologists and had variable follow‐up practices.

Conclusion

Engagement with outpatient oncologists throughout patient admissions may contribute to more effective discharge planning. Inpatient teams can use this strategy to help improve hospital transitions of care for patients with cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HospitalistsNeoplasmsMedical OncologyHumansFemaleMaleMiddle AgedAgedPatient ReadmissionPatient Care TeamPatient DischargeLength of StayHospitalizationPatient Admission

Stichwörter der Autor:innen

mixed‐methodsoncology hospitalistoutpatientteam communicationteaming

Autor:innen und Institutionen

  • Department of Health Economics, Systems, and Policy, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Research and Development Service, Dallas VA Medical Center, Dallas, Texas, USA.

ORCID-Profile: Megan A Mullins, Sanah Ladhani, Emily C Repasky, Navid Sadeghi

Förderung

  • Texas Health Resources Clinical Scholar Award
  • National Center for Advancing Translational Sciences of the National Institutes of Health

Zitieren

APA

Mullins, M. A., Ladhani, S., Carrillo, A., Repasky, E. C., Wu, M., Etingen, B., Tarhan, E., Sadeghi, N., Fleming, J. B., Conzen, S. D., & Hong, A. S. (2026). Hospitalist Care for Unplanned Oncology Admissions: A Mixed‐Method Analysis of Oncology and General Hospitalist Outcomes and Processes. Cancer Medicine, 15(3). https://doi.org/10.1002/cam4.71679

Vancouver

Mullins MA, Ladhani S, Carrillo A, Repasky EC, Wu M, Etingen B, et al. Hospitalist Care for Unplanned Oncology Admissions: A Mixed‐Method Analysis of Oncology and General Hospitalist Outcomes and Processes. Cancer Medicine. 2026;15(3). doi:10.1002/cam4.71679

BibTeX
@article{Mullins2026,
  author = {Mullins, Megan A and Ladhani, Sanah and Carrillo, Abril and Repasky, Emily C and Wu, Michael and Etingen, Bella and Tarhan, Emre and Sadeghi, Navid and Fleming, Jason B and Conzen, Suzanne D and Hong, Arthur S},
  title = {Hospitalist Care for Unplanned Oncology Admissions: A Mixed‐Method Analysis of Oncology and General Hospitalist Outcomes and Processes},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {3},
  doi = {10.1002/cam4.71679}
}
Kostenlos starten →